What This Means
This research followed 48 patients who experienced bleeding around the brain caused by a ruptured aneurysm (called aneurysmal subarachnoid hemorrhage, or aSAH) and tracked how their immune systems responded over the first nine days. The researchers measured ten different immune signaling proteins (cytokines) in the blood and, in a smaller group of 16 patients, analyzed specific immune cell populations. They found that the immune response was not uniform: some inflammatory proteins (IL-6, IL-18, and IL-15) were elevated immediately and stayed high throughout the observation period, while others (IL-7, IL-12p40, IP-10, and CXCL-9) only rose later in the recovery process. Patients who had worse outcomes at three months tended to have higher levels of IL-6 and IL-15, while those who recovered better had higher levels of IL-22. However, when accounting for how severe the initial hemorrhage was, these cytokine differences no longer independently predicted outcomes, suggesting the cytokine levels largely mirror how sick the patients were to begin with rather than being separate predictors of recovery.
The study also found a notable and persistent reduction in a specialized type of immune cell called MAIT (mucosal-associated invariant T) cells in the bloodstream of aSAH patients, while other similar immune cell types were relatively unaffected. MAIT cells are part of the innate-like immune system and play roles in responding to infection and regulating inflammation. The reduction in a specific subtype of MAIT cells (double-negative MAIT cells) was consistently linked to higher levels of the inflammatory protein IL-18, suggesting these two immune changes may be connected.
This research suggests that aSAH triggers a complex, time-dependent immune response that selectively depletes certain immune cell populations. The persistent loss of MAIT cells and their relationship with IL-18 may offer new avenues for understanding the immune-related brain injury that occurs after aneurysm rupture. While cytokine levels were associated with patient outcomes, their link to disease severity means they may serve more as markers of how serious the hemorrhage is rather than as independent targets or predictors—an important distinction for future research aiming to develop immune-based therapies for this serious condition.